Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 94

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 94
---
 we, or any future
    license partners or collaborators, might not have been the first to file patent applications covering certain aspects of the
    concerned technologies;

    ●
    others may independently
    develop similar or alternative technologies, or duplicate any of our technologies, potentially without falling within the
    scope of our current or future issued claims, thus not infringing our intellectual property rights;

    ●
    it is possible that
    our filed or future patent applications will not lead to issued patents;

54 

    ●
    issued patents to
    which we currently hold rights or to which we may hold rights in the future may be held invalid or unenforceable, including
    as a result of legal challenges by our competitors;

    ●
    others may have
    access to any future intellectual property rights licensed to us on a non-exclusive basis;

    ●
    our competitors
    might conduct research and development activities in countries where we have or intend to pursue patent rights, and then use
    the information learned from such activities to develop competitive products for sale in our major commercial markets where
    we do not have patent rights;

    ●
    we may not develop
    additional proprietary technologies that are patentable;

    ●
    the patents or other
    intellectual property rights of others may have an adverse effect on our business; and

    ●
    we may choose not
    to file a patent application covering certain of our trade secrets or know-how, and a third party may subsequently file a
    patent covering such intellectual property.

Should
any of these events occur, they could significantly harm our business, financial condition, results of operations and prospects.

If
we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. Our
reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover
them or that our trade secrets will be misappropriated or disclosed.

In
addition to patent protection, we also rely on the protection of trade secrets, know-how and confidential and proprietary information.
The disclosure of our trade secrets would impair our competitive position and could harm our business. However, trade secrets
are difficult to protect. To maintain the confidentiality of trade secrets and proprietary information, we rely in part on confidentiality
agreements with our employees, consultants, outside scientific collaborators, sponsored researchers, and/or other advisors, and
inventions agreements with employees, consultants, and advisors, to